Detailed Narrative
Robust Financial Performance in Q4 and FY26
Indo Borax & Chemicals Ltd. reported a strong financial close to FY26, with operating revenue growing 22.9% to Rs. 215.45 crores for the full year. Net profit for FY26 increased 18% to Rs. 50.27 crores. The fourth quarter alone saw a 25.70% rise in operating revenue to Rs. 63.01 crores and a 41.9% increase in PAT to Rs. 14.53 crores. The company maintained healthy EBITDA and PAT margins of 21.8% and 20.5% respectively for FY26, reflecting improved operational efficiencies.
Strategic Transformation and New Leadership
FY26 marked a significant transformation for Indo Borax with Zenrock Chemicals emerging as the new promoter and a new leadership team taking charge. This team, including MD & CEO Mr. Suresh Kalra, is focused on fiscal discipline, operational excellence, and value creation. The company monetized non-core assets, which contributed to a special dividend of Rs. 30 per equity share, in addition to the 1000% final dividend, totaling Rs. 40 per share for the year.
Product Portfolio and Market Leadership
The company holds a leading position in the Indian Boric Acid market with almost 50% market share. Its core products include Boric Acid Technical (~15,000 tons sales), Boric Acid I.P. (~900 tons), and Disodium Octaborate Tetrahydrate (DOT) (~980 tons sales). Indo Borax is the sole manufacturer of IP-grade Boric acid in India. The manufacturing facility in Pithampur has a capacity of 26,000 tons per annum, comprising 20,000 tons of Boric Acid and 6,000 tons of DOT.
Growth Strategy and Capacity Expansion
Management aims for 20-35% revenue growth in the coming year, targeting over Rs. 250 crores, driven by increased realizations, operational efficiencies, and new products. While Boric Acid capacity is nearly fully utilized, the company plans to increase DOT sales from 980 tons to 1,500 tons in the coming year, leveraging its 6,000-ton capacity. They are also actively exploring Boron Oxide, with the first lot expected in 3-4 quarters, and plan to introduce more product lines through CAPEX and R&D.
Raw Material Sourcing and Margin Stability
The company sources Ulexite Ore from Turkey, South America, and North America and is actively diversifying its supply chain to mitigate geopolitical risks. Management noted that raw material price volatility in their sector is less severe compared to other chemical sectors. They are confident in maintaining current EBITDA margins of 20-21% due to long-term contracts and the ability to pass on price increases to customers within the value chain.
Capital Allocation and Liquidity Management
Indo Borax & Chemicals Ltd. maintains a zero-debt position. The company holds approximately Rs. 70 crores in other financial assets (FDs) and has increased its investments by Rs. 130 crores into mutual funds. This liquidity strategy aims to support upcoming CAPEX expansions and new opportunities. CAPEX plans for capacity expansion and product portfolio broadening are currently under discussion, with details expected post board approval.